Skip to Main Content

Paper Details

Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
J Child Adolesc Psychopharmacol
15
2014

Datasets

Release 1.2